Our research program is focused on supporting readiness to respond to current and future global pandemics. The CLS is always accepting proposals for work actively contributing to pandemic response, supporting research into pandemic-related treatments or vaccines, or improving conditions for frontline workers. Below are examples of some of the research related to COVID-19 that has been conducted at our facility.
Although the COVID-19 pandemic may feel like it is winding down for many people, there is still much to be learned about the virus that could help us to keep it at bay in the future.
Developing therapeutics for COVID-19 should lessen the length and severity of the illness, keeping more people out of the hospital and improving patient outcomes.
Using the CLS, McGill researchers have discovered a small molecule that may help combat COVID-19 and could contribute to a new arsenal of treatments slowly making their way to market.
Researchers from the University of Toronto have developed antibodies that can neutralize COVID-19.
Using the CLS, researchers have isolated some promising inhibitors that could be used to treat COVID-19 infections.
Dr. Jake Pushie is using the CLS and VIDO to study the virus that causes COVID-19 and its effects on blood vessels.
University of Saskatchewan scientists have designed an air sanitizing device that could help protect us from airborne pathogens like the ones that cause COVID-19 and the common flu.
Researchers are working to better understand how decontamination procedures might affect the structure and potential reuse of N95 masks.
A University of Nevada researcher is using our Mid-IR beamline to study how nucleic acids get damaged under X-ray irradiation.
Researchers from the CLS and Université Laval are trying to create a device that would make healthcare testing more efficient
University of Calgary researchers are developing therapeutics for COVID-19.
Dr. Jiang Yin is using the CLS to find new therapies that will help treat COVID-19.
